九典制药:销售费用率大幅优化,高基数下Q2表现超预期

九典制药(300705.SZ)/化学 制药 证券研究报告/公司点评 2024 年 08 月 25 日 | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...